Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 3

Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease

Total article views   HTML views PDF downloads Totals
4,444 Dovepress* 4,444+ 1,604 6,048
Totals 4,444 1,604 6,048
*Since 15 September 2006
+Since July 2016

View citations on Google Scholar